Cerner Announces Next Evolution of Cerner Millennium®

CernerCerner (Nasdaq: CERN) announced the launch of Millennium+™, the next evolution of Cerner Millennium®. Combining the enterprise platform with the secure Cerner Cloud, Millennium+ delivers a new user experience that is fast, smart and easy. It provides personalized, intuitive and relevant clinical workflows via the desktop, tablet and smartphone.

Cerner understands the importance of health system and community interoperability, which is why Millennium+ integrates and unifies information gathered within the organization and across the community into a provider's workflow. Millennium+ is designed to speed up workflows, reduce clicks and ensure Cerner solutions provide each user the information they need at the right point in the workflow in context of the person, condition and venue.

In addition to Sepsis alerting and Chart Search, one of the first solutions that will be launched as part of the Millennium+ platform is PowerChart+Touch™. PowerChart+Touch was created specifically for the iPad. With a swipe of a finger, providers can quickly and easily navigate workflows. As part of the Millennium+ platform, solutions are available on-demand versus relying on major release schedules to access to new capabilities. This provides client organizations, departments and individual users to more quickly adapt to new capabilities, regulatory mandates and quality measurements.

"Cerner is going beyond foundational automation of the health record and creating a new experience; not just a repository to chart activity or place orders," said Jeff Townsend, Cerner chief of staff and executive VP. "With this new combination of capabilities, Cerner is well positioned to accelerate innovation around the second order effects of a digitized industry. What you can do now with Millennium+ is much more than just being paperless, it moves the boundaries beyond a typical Enterprise Health Record system."

Millennium+ creates a new user experience that is:

Fast

  • Millennium+ is designed for optimal performance. The solution speeds up access to comprehensive clinical workflows, anticipating the data requirements to complete end-to-end experiences while reducing clicks and improving context of care.

Smart

  • Millennium+ is smart and aware of the context of the patient, the location and the user. It anticipates "next," and brings information face up in the context of the next decision or action, making it moment relevant.

Easy

  • Millennium+ is easy to use. The interaction is intuitive, with minimal training and configuration required.

Millennium+ solutions are currently rolling out to physicians through the end of the year and to additional providers through 2013.

About Cerner
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we’ve learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.

Cerner® solutions are licensed by approximately 9,300 facilities around the world, including more than 2,650 hospitals; 3,750 physician practices; 40,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 40 employer sites and 1,600 retail pharmacies.

Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN.

Most Popular Now

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...